3 Biotech Stocks to Sell Before They Damage Your Portfolio 

InvestorPlace – Stock Market News, Stock Advice & Trading Tips

There are several reasons that investors should be cautious about buying or holding biotech stocks at this point. First, the Street is generally bearish on the sector lately. In July, Barron provided evidence of that trend when it reported that the shares of a number of biotech stocks had fallen in the preceding week immediately after their drugs were approved by the Food and Drug Administration (FDA).